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A b s t r A c t
Toxic leukoencephalopathy occurs as a result of exposure to a wide variety of drugs 
such as cocaine, ethanol, 3,4-ethylenedioxymethamphetamine, intravenous heroin, 
psilocybin, toluene as well as inhaled heroin pyrolysate. The leukoencephalopathy 
caused by inhaled heroin called “chasing the dragon” results in characteristic signal 
abnormalities on MRI but may present similarities to other toxic leukoencephalopa-
thies as well. We present a case of heroin vapour abuse with a cerebral MRI present-
ing symmetrical T2 hyperintensities in both of the temporal lobes, the centrum semio-
vale, the right occipital lobe, and the splenium of the corpus callosum, with restricted 
diffusion. The MRI findings quickly improved and the patient gradually recovered.
I n t r o d u c t I o n
The use of heroin, a diacetyl derivate of morphine, is common among drug ad-
dicts. Heroin may be used in different ways: intravenously, subcutaneously, smoked, 
sniffed, or inhaled. 
The term “chasing the dragon”, or “chinesing” or “chinese blowing” originates 
in the 1920s’ China and became rather popular in the 1950s in Hong Kong, since that 
impure drug form was cheap and thus widely consumed. To consume a small quantity 
of powder it is placed on an aluminum foil and then heated with a lighter. The heroin 
powder liquefies into a reddish brown glob (pyrolysate), emitting a white vapor, called 
“dragon” which is “chased” with the lighter underneath while the vapor is sucked 
through a straw or pipe. Heroin intended for smoking is usually 30% to 40% pure, since 
the purest forms degrade too quickly for effective smoking. Additionally, according to 
reports, heroin is mainly available in a non-intravenous base form1.
That form is linked to toxic leukoencephalopathy although the exact pathogenesis 
is still unclear with characteristic and highly specific signal abnormalities on MRI, 
which can greatly aid in proper diagnosis2. The term leukoencephalopathy generally 
refers to a disease of the white matter of the brain and therefore this entity involves 
motor, sensory and visual systems. Leukoencephalopathy can also disrupt cognitive 
and emotional functions. The clinical manifestations of the disease reflect the areas of 
the brain damaged as the disease processes. Clinical features range from inattention, 
forgetfulness and personality changes, to dysarthria, ataxia, dementia, coma and death.
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AbbreviAtions
CΤ scan: computed tomography
DWI: diffusion weighted image
FLAIR: fluid attenuation inversion 
recovery
MRI: magnetic resonance imaging
NAA: N-acetylaspartate
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c A s e  p r e s e n t A t I o n
Our patient was a 23 year old female presenting in the ER 
with dysarthria, bradykinesia, and ataxia. The patient inhaled 
heroin one week before the onset of the symptoms. She was 
tachypneic, but hemodynamically stable (145/90 mmHg) with a 
normal sinus rhythm. Corneal reflexes were present bilaterally 
and the motor examination revealed axial myoclonus. General 
examination revealed no cardiac murmurs, whilst the chest 
and abdomen were unremarkable. No needle marks were 
observed on the skin.
A brain CT scan revealed low attenuation regions bilater-
ally involving the temporal lobes, the splenium of the corpus 
callosum and the centrum semiovale. 
Further evaluation with MRI imaging (Fig. 1) showed 
symmetric hyperdensity concerning both the temporal lobes, 
the splenium of the corpus callosum, the centrum semiovale 
and an area in the right occipital lobe on T2W images and 
fluid-attenuated inversion recovery sequence (FLAIR). Dif-
fusion weighted imaging (DWI) showed abnormal restricted 
diffusion in these areas, while contrast-enhanced axial T1W 
image demonstrated enhancement bilaterally in the temporal 
lobes and right occipital lobe. 
The MRI findings (Fig. 2) improved in 13 days and the 
patient gradually recovered. After 13 days a new MRI revealed 
the absence of hyperdensity while the enhancement remained 
practically the same.
d I s c u s s I o n
The first and largest outbreak of this type of toxic leukoen-
cephalopathy linked to “chasing the dragon” was reported 
in1982 in the Netherlands, and included 47 cases, 11 (23%) of 
whom died3. Since then, similar cases have been reported spo-
radically in both Europe and the united States. The primary 
hypothesis, although a specific etiology was not identified is 
that a contaminant in the heroin or a combustion by-product 
causes the lesions mentioned above4. Additionally, Buxton et 
al support that there is also a dose depending response effect 
FIgure 1. 23 year old female who had inhaled heroin 1 week before. (A) Axial T2-weighted MR image and (b) FLAIR image: hy-
perintensity in the temporal lobes and an area of hyperintensity in the right occipital lobe. (C) Axial DWI reveals restricted diffusion 
bilaterally in the temporal lobes and right occipital lobe, (d) in the right occipital lobe and splenium and in the centrum semiovale. 
(E) Contrast-enhanced axial T1W image demonstrates enhancement bilaterally in the temporal lobes and right occipital lobe.
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rather than a genetic predisposition to the manifestation of 
the disease5.
Thorough investigation revealed severe changes in the 
white matter, termed vacuolating myelinopathy, lesions that 
are characterized by the formation of vacuoles in the oligoden-
droglia, resulting in a spongiform degeneration6. Mitochon-
drial dysfunction may be critical as well in the development of 
heroin leukoencephalopathy, as suggested by mitochondrial 
changes on specimens from brain biopsies. Magnetic resonance 
spectroscopy may show abnormally elevated intracerebral 
lactate in the affected white matter as well as decreased levels 
of NAA in the white matter, gray matter and cerebellum, pos-
tulating that these findings reflect mitochondrial toxicity while 
Proton MR spectroscopy is not essential in the diagnosis but 
may help in elucidating the nature of the condition7,8.
Clinical improvement after administering antioxidant 
therapy such as coenzyme Q and vitamin supplements may 
be beneficial as seen with our patient and reported in a few 
other cases7.
Gupta et al. reported a case of heroin vapour abuse 
manifestated by altered sensorium and rhabdomyolysis-related 
renal failure with symmetrical involvement of cerebellar hemi-
spheres and hippocampi initially and delayed involvement of 
basal ganglia9.
There are also similarities to other toxic leukoencephalopa-
thies with widespread white matter hyperdensity involving both 
supra and infratentorial compartments, with characteristic 
symmetrical involvement of the posterior limb of the internal 
capsules and the cerebellar white matter. The subcortical u-
fibers seem to be spared. The frontal region may be relatively 
spared as well while affected areas show diffusion restriction. 
Since most part of the available literature so far has been 
selectively published in neurology and radiology journals in 
the form of clinical case reports, those isolated cases make it 
difficult to determine possible risk factors for this condition 
in biochemical and molecular level5.
c o n c l u s I o n
Whilst the presented form of leucoencephalopathy seems 
to be clearly a drug abuse induced disease, we also decided 
FIgure 2. MRI findings after 13 days of hospitalization. (A) Axial T2-weighted MR image and (b) FLAIR image : demonstrate 13 
days later absence of hyperintensity. (C) Axial DWI shows not restricted diffusion in the temporal lobes and right occipital lobe, (d) 
in the right occipital lobe and splenium and (e) in the centrum semiovale. (F) Contrast-enhanced axial T1W image demonstrates a 
reduction of the enhancement in the temporal lobes.
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to record our case in order underline the lack of literature 
references concerning an entity which, taking for granted the 
economical and social changes in modern societies and the 
drug use tendencies, may present a greater prevalence among 
the general population affecting mostly young drug users of 
poor incomes unable to obtain pure forms of heroin. The un-
derstanding of the exact causes my help in the development of 
a precise early diagnostic tool and initiating an effective and 
evidence based treatment. MRI is the imaging modality which 
allows the diagnosis of toxic leucoencephalopathy, determines 
the extent of the pathology and assesses the effect of treatment 
during follow up exams.
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